Ellington Management Group’s Insmed INSM Stock Holding History

Ellington Management Group’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-24,300	Closed	-$429K	–	640
2019 Q3	$429K	Buy	+24,300	New	+$469K	0.08%	263
2017 Q4	–	Sell	-9,600	Closed	-$300K	–	694
2017 Q3	$300K	Buy	+9,600	New	+$183K	0.05%	378
2016 Q2	–	Sell	-23,100	Closed	-$293K	–	362
2016 Q1	$293K	Buy	+23,100	New	+$304K	0.13%	241

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Ellington Management Group's INSM Position: Q4 2019 in Review

Ellington Management Group sold out of Insmed (INSM) in Q4 2019, closing a stake of 24,300 shares — an estimated $429K sold.

Ellington Management Group first reported a position in INSM in Q1 2016 and held it in 3 quarters. The position peaked at $429K in Q3 2019. 176 funds tracked by Wall St. Rank hold INSM as of Q4 2019.

Ellington Management Group reported no remaining Insmed position as of Q4 2019 after selling out during the quarter.
Ellington Management Group sold 24,300 Insmed shares in Q4 2019, an estimated $429K.
Ellington Management Group first reported a position in Insmed in Q1 2016 and held it in 3 quarters.
Ellington Management Group's Insmed position peaked at $429K in Q3 2019.
176 funds tracked by Wall St. Rank held Insmed as of Q4 2019.

Based on Ellington Management Group's 13F filing for Q4 2019, filed 14 Feb 2020.